Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, 01 mars 2022 (GLOBE NEWSWIRE) -- Excellence Canada a le plaisir d’annoncer la publication de deux Normes d’excellence actualisées très attendues, Santé mentale au travail et Milieu de...
-
TORONTO, March 01, 2022 (GLOBE NEWSWIRE) -- Excellence Canada is pleased to announce the release of two highly anticipated and updated management systems, the Mental Health at...
-
Fraser Institute News Release: New essay celebrates key ideas and contributions of Deirdre McCloskey
VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- A new essay—part of a collected series summarizing the lives and ideas of women who helped shape the free and prosperous societies we...
-
WINNIPEG, Manitoba, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Today, Protein Industries Canada announced a co-investment into the second phase of Canada’s National Index on Agri-Food Performance, alongside...
-
Mineralization outside and to the east of the current pit-constrained 2.08M ounce Indicated resourceNorth Block regional drill program commences testing Talisman and Horseshoe ZonesSouth Block...
-
AUSTIN, Texas, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Strangeworks, a global leader in quantum computing software, today announced its latest collaboration with Quantum Algorithms Institute, a...
-
Toronto, Canada, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Today Superette Inc. (“Superette” or the “Company”) announces the acquisition of Cannoe Corp. (“Cannoe”) and concurrent $5M financing in a...
-
TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- New polling released today by the Ontario Real Estate Association (OREA) shows Ontario’s older parents greatly value the importance of home ownership – so...
-
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR RECU L’AUTORISATION DE HEALTH CANADA POUR SOUMETTRE UNE DEMANDE DE MISE SUR LE MARCHE DU MASITINIB DANS LE TRAITEMENT DE LA SCLEROSE LATERALE...
-
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS GRANTED AUTHORIZATION TO FILE A NEW DRUG SUBMISSION FOR MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) UNDER THE NOTICE OF...